Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 339

1.

An NGF mimetic, MIM-D3, stimulates conjunctival cell glycoconjugate secretion and demonstrates therapeutic efficacy in a rat model of dry eye.

Jain P, Li R, Lama T, Saragovi HU, Cumberlidge G, Meerovitch K.

Exp Eye Res. 2011 Oct;93(4):503-12. doi: 10.1016/j.exer.2011.06.014. Epub 2011 Jun 25.

PMID:
21726552
2.

Efficacy of topical nerve growth factor treatment in dogs affected by dry eye.

Coassin M, Lambiase A, Costa N, De Gregorio A, Sgrulletta R, Sacchetti M, Aloe L, Bonini S.

Graefes Arch Clin Exp Ophthalmol. 2005 Feb;243(2):151-5. Epub 2005 Jan 14.

PMID:
15650854
3.

In vitro evidence of nerve growth factor effects on human conjunctival epithelial cell differentiation and mucin gene expression.

Lambiase A, Micera A, Pellegrini G, Merlo D, Rama P, De Luca M, Bonini S, Bonini S.

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4622-30. doi: 10.1167/iovs.08-2716. Epub 2009 Apr 30.

PMID:
19407015
4.

Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.

Solomon A, Dursun D, Liu Z, Xie Y, Macri A, Pflugfelder SC.

Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2283-92.

PMID:
11527941
5.

Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.

Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC.

Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4293-301.

PMID:
15557435
6.

Effects of DA-6034 on aqueous tear fluid secretion and conjunctival goblet cell proliferation.

Choi SM, Lee YG, Seo MJ, Kang KK, Ahn BO, Yoo M.

J Ocul Pharmacol Ther. 2009 Jun;25(3):209-14. doi: 10.1089/jop.2008.0126.

PMID:
19456255
7.

Time course of ocular surface and lacrimal gland changes in a new scopolamine-induced dry eye model.

Viau S, Maire MA, Pasquis B, Grégoire S, Fourgeux C, Acar N, Bretillon L, Creuzot-Garcher CP, Joffre C.

Graefes Arch Clin Exp Ophthalmol. 2008 Jun;246(6):857-67. doi: 10.1007/s00417-008-0784-9. Epub 2008 Mar 21.

PMID:
18357464
8.

A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride.

Xiong C, Chen D, Liu J, Liu B, Li N, Zhou Y, Liang X, Ma P, Ye C, Ge J, Wang Z.

Invest Ophthalmol Vis Sci. 2008 May;49(5):1850-6. doi: 10.1167/iovs.07-0720.

PMID:
18436819
9.
11.

Keratoconjunctivitis sicca modifies epithelial stem cell proliferation kinetics in conjunctiva.

Chen W, Zhao K, Li X, Yoshitomi T.

Cornea. 2007 Oct;26(9):1101-6.

PMID:
17893543
12.

Improvement of corneal barrier function by the P2Y(2) agonist INS365 in a rat dry eye model.

Fujihara T, Murakami T, Fujita H, Nakamura M, Nakata K.

Invest Ophthalmol Vis Sci. 2001 Jan;42(1):96-100.

PMID:
11133853
13.

Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.

Choi W, Li Z, Oh HJ, Im SK, Lee SH, Park SH, You IC, Yoon KC.

Curr Eye Res. 2012 Jan;37(1):12-7. doi: 10.3109/02713683.2011.622852. Epub 2011 Oct 26.

PMID:
22029739
14.

No consequences of dietary n-3 polyunsaturated fatty acid deficiency on the severity of scopolamine-induced dry eye.

Viau S, Pasquis B, Maire MA, Fourgeux C, Grégoire S, Acar N, Bretillon L, Creuzot-Garcher CP, Joffre C.

Graefes Arch Clin Exp Ophthalmol. 2011 Apr;249(4):547-57. doi: 10.1007/s00417-010-1576-6. Epub 2010 Dec 16.

PMID:
21161262
15.

Conjunctival cytokine expression in symptomatic moderate dry eye subjects.

Narayanan S, Miller WL, McDermott AM.

Invest Ophthalmol Vis Sci. 2006 Jun;47(6):2445-50.

PMID:
16723455
16.

Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.

Lee HK, Ryu IH, Seo KY, Hong S, Kim HC, Kim EK.

Ophthalmology. 2006 Feb;113(2):198-205. Epub 2005 Dec 19.

PMID:
16360211
17.

Efficacy of combined 0.05% cyclosporine and 1% methylprednisolone treatment for chronic dry eye.

Byun YJ, Kim TI, Kwon SM, Seo KY, Kim SW, Kim EK, Park WC.

Cornea. 2012 May;31(5):509-13. doi: 10.1097/ICO.0b013e31818c69ef.

PMID:
19730097
18.

The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects.

Yen MT, Pflugfelder SC, Feuer WJ.

Am J Ophthalmol. 2001 Mar;131(3):314-23.

PMID:
11239863
19.

Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.

Pflugfelder SC, De Paiva CS, Villarreal AL, Stern ME.

Cornea. 2008 Jan;27(1):64-9. doi: 10.1097/ICO.0b013e318158f6dc.

PMID:
18245969
20.

Apoptosis of ocular surface cells in experimentally induced dry eye.

Yeh S, Song XJ, Farley W, Li DQ, Stern ME, Pflugfelder SC.

Invest Ophthalmol Vis Sci. 2003 Jan;44(1):124-9.

PMID:
12506064
Items per page

Supplemental Content

Write to the Help Desk